The Lancet Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Publishing
Founded:1823
Lead Investor(s):N/A

Estimated Revenue & Financials

  • The Lancet's estimated annual revenue is currently $39.6M per year.(?)
  • The Lancet's estimated revenue per employee is $243,000

Employee Data

  • The Lancet has 163 Employees.(?)
  • The Lancet grew their employee count by 12% last year.
  • The Lancet currently has 1 job openings.

The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals in the fields of child & adolescent health, diabetes and endocrinology, gastroenterology and hepatology, global health, HIV, haematology, infectious diseases, neurology, oncology, planetary health, psychiatry, public health, planetary health, and respiratory medicine. It retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. Learn more at - http://bit.ly/Lancet_LinkedIn The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.

keywords:Healthcare,Pharmaceuticals